CollabRx, Inc. Schedules Second Quarter Fiscal Year 2014 Financial Conference Call and Business Update

San Francisco, Calif., November 5, 2013 – CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on November 13, 2013 to discuss the Company’s financial results for the second quarter of fiscal 2014 and to provide an update about the business in the current fiscal year.

The dial-in number for the live audio call beginning on Wednesday, November 13, 2013, at 5 p.m. EST (2 p.m. PST) is (877) 369-6591 in the U.S. and (253) 237-1176 for international participants.  The conference identification number is 88439990. A live webcast of the conference call will also be available at:

A webcast replay of the call will be available for one year and may be accessed at the same link:

About CollabRx

CollabRx, Inc. (NASDAQ: CLRX) is a data analytics company and a leader in cloud-based expert systems to inform health care decision-making. CollabRx uses information technology to aggregate and contextualize the world’s knowledge on genomics-based medicine with specific insights from the nation’s top cancer experts starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. More information may be obtained at

CollabRx Contacts:
Thomas R. Mika, Chairman and CEO
CollabRx, Inc.

James Carbonara, Regional Vice President
Hayden IR




Connect With Us
Join other physicians who are receiving our updates.
We hate spam. Your email address will not be sold or shared with anyone else.